# The Richline Group Inc – FDA Inspection, Nov 3, 2016

Source: https://www.keypedia.com/records/fda_inspections/the-richline-group-inc/0329b8cf-a1f1-4d49-be46-61fa8b1cde00
Source feed: FDA_Inspections

> FDA inspection 996820 of The Richline Group Inc, November 03, 2016. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 996820
- Company Name: The Richline Group Inc
- Inspection Date: 2016-11-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1266961 - 2025-04-16](https://www.keypedia.com/records/fda_inspections/the-richline-group-inc/8c95120f-7362-4b47-adf1-381fe50d3350)
- [FDA Inspection 1226962 - 2024-01-12](https://www.keypedia.com/records/fda_inspections/the-richline-group-inc/3bcaf94b-d9d3-4a4c-8331-9b36f32f12ae)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jennifer-lalama/5ebc4da1-62ac-4b15-89a8-e18b0606e0ff)

Company: https://www.keypedia.com/companies/the-richline-group-inc/f159a897-3841-4112-9253-89e8b2ae3901

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
